Skip to main content
. 2017 Jul 26;2017:9032792. doi: 10.1155/2017/9032792

Figure 4.

Figure 4

Effects of GTPs and HFD on the β-hydroxybutyrate concentration and the expression of a ketogenic rate-limiting enzyme. (a, b) β-Hydroxybutyrate concentrations in the kidney and serum. (c, d) Western blot and density analyses of renal HMGCS2 protein expression. The data are represented as the mean ± SD (n = 5–9); P < 0.05 versus the control group and #P < 0.05 versus the HFD group.